NAR Cancer: 2023, vol: 5, issue: 3
- 1)- Si Hoi Kou, Jiaheng Li, Benjamin Tam, Huijun Lei, Bojin Zhao, Fengxia Xiao, San Ming Wang. germline pathogenic variants in modern humans were likely originated during recent human history. NAR cancer. 2023, 5 (3): zcad025
Cited : 6Read More - 2)- Meng Wang, Prethish Sreenivas, Benjamin D Sunkel, Long Wang, Myron Ignatius, Benjamin Z Stanton. The 3D chromatin landscape of rhabdomyosarcoma. NAR cancer. 2023, 5 (3): zcad028Cited : 6Read More
- 3)- Jan Benada, Daria Bulanova, Violette Azzoni, Valdemaras Petrosius, Saba Ghazanfar, Krister Wennerberg, Claus Storgaard Sørensen. Synthetic lethal interaction between WEE1 and PKMYT1 is a target for multiple low-dose treatment of high-grade serous ovarian carcinoma. NAR cancer. 2023, 5 (3): zcad029Cited : 8Read More
- 4)- Dylan Pelletier, Anne-Laure Chong, Mona Wu, Leora Witkowski, Sophie Albert, Nelly Sabbaghian, Marc R Fabian, William D Foulkes. DICER1 platform domain missense variants inhibit miRNA biogenesis and lead to tumor susceptibility. NAR cancer. 2023, 5 (3): zcad030Cited : 1Read More
- 5)- Junhong Guan, Guo-Min Li. DNA mismatch repair in cancer immunotherapy. NAR cancer. 2023, 5 (3): zcad031Cited : 7Read More
- 6)- Madhura R Pandkar, Adarsh Raveendran, Kajal Biswas, Srinivas Abhishek Mutnuru, Jharna Mishra, Atul Samaiya, Tyler Malys, Alexander Y Mitrophanov, Shyam K Sharan, Sanjeev Shukla. PKM2 dictates the poised chromatin state of promoter to enhance breast cancer progression. NAR cancer. 2023, 5 (3): zcad032Cited : 3Read More
- 7)- Juliet D Strauss, Zachary F Pursell. Replication DNA polymerases, genome instability and cancer therapies. NAR cancer. 2023, 5 (3): zcad033Cited : 6Read More
- 8)- Susan M Grimes, Heon Seok Kim, Sharmili Roy, Anuja Sathe, Carlos I Ayala, Xiangqi Bai, Alison F Almeda-Notestine, Sarah Haebe, Tanaya Shree, Ronald Levy, Billy T Lau, Hanlee P Ji. Single-cell multi-gene identification of somatic mutations and gene rearrangements in cancer. NAR cancer. 2023, 5 (3): zcad034Cited : 3Read More
- 9)- Daniel Croft, Puja Lodhia, Sofia Lourenco, Craig MacKay. Effectively utilizing publicly available databases for cancer target evaluation. NAR cancer. 2023, 5 (3): zcad035Cited : 3Read More
- 10)- Ryan A Neff, Almudena Bosch-Gutierrez, Yifei Sun, Igor Katsyv, Won-Min Song, Minghui Wang, Martin J Walsh, Bin Zhang. Dysfunction of ubiquitin protein ligase leads to cell resilience in human breast cancers. NAR cancer. 2023, 5 (3): zcad036Cited : 0Read More
- 11)- Tatiana Belova, Nicola Biondi, Ping-Han Hsieh, Pavlo Lutsik, Priya Chudasama, Marieke L Kuijjer. Heterogeneity in the gene regulatory landscape of leiomyosarcoma. NAR cancer. 2023, 5 (3): zcad037Cited : 1Read More
- 12)- Akinsola Oyelakin, Jennifer Sosa, Kasturi Bala Nayak, Alexandra Glathar, Christian Gluck, Isha Sethi, Maria Tsompana, Norma Nowak, Michael Buck, Rose-Anne Romano, Satrajit Sinha. An integrated genomic approach identifies follistatin as a target of the p63-epidermal growth factor receptor oncogenic network in head and neck squamous cell carcinoma. NAR cancer. 2023, 5 (3): zcad038Cited : 1Read More
- 13)- Victoria E Brown, Sydney L Moore, Maxine Chen, Nealia House, Philip Ramsden, Hsin-Jung Wu, Scott Ribich, Alexandra R Grassian, Yoon Jong Choi. CDK2 regulates collapsed replication fork repair in CCNE1-amplified ovarian cancer cells via homologous recombination. NAR cancer. 2023, 5 (3): zcad039Cited : 1Read More
- 14)- Anastasiya Kazachenka, Jane Hc Loong, Jan Attig, George R Young, Piyali Ganguli, Ginny Devonshire, Nicola Grehan, , Francesca D Ciccarelli, Rebecca C Fitzgerald, George Kassiotis. The transcriptional landscape of endogenous retroelements delineates esophageal adenocarcinoma subtypes. NAR cancer. 2023, 5 (3): zcad040Cited : 0Read More
- 15)- Asta M Rasmussen, Trine Line H Okholm, Michael Knudsen, Søren Vang, Lars Dyrskjøt, Thomas B Hansen, Jakob S Pedersen. Circular stable intronic RNAs possess distinct biological features and are deregulated in bladder cancer. NAR cancer. 2023, 5 (3): zcad041Cited : 3Read More
- 16)- Minwoo Wie, Keon Woo Khim, Arnold S Groehler Iv, Soomin Heo, Junhyeok Woo, Kook Son, Eun A Lee, Jae Sun Ra, Sung You Hong, Orlando D Schärer, Jang Hyun Choi, Kyungjae Myung. Alkylation of nucleobases by 2-chloro--diethylethanamine hydrochloride (CDEAH) sensitizes -deficient tumors. NAR cancer. 2023, 5 (3): zcad042Cited : 0Read More
- 17)- Adèle Beneyton, Louis Nonfoux, Jean-Philippe Gagné, Amélie Rodrigue, Charu Kothari, Nurgul Atalay, Michael J Hendzel, Guy G Poirier, Jean-Yves Masson. The dynamic process of covalent and non-covalent PARylation in the maintenance of genome integrity: a focus on PARP inhibitors. NAR cancer. 2023, 5 (3): zcad043Cited : 4Read More
- 18)- Robert W Sobol. Editorial: DNA repair and nucleic acid therapeutics in cancer. NAR cancer. 2023, 5 (3): zcad044Cited : 0Read More
- 19)- Andrej Zivanovic, Jeffrey T Miller, Sarah A Munro, Todd P Knutson, Yingming Li, Courtney N Passow, Pijus Simonaitis, Molly Lynch, LeAnn Oseth, Shuang G Zhao, Felix Y Feng, Pernilla Wikström, Eva Corey, Colm Morrissey, Christine Henzler, Benjamin J Raphael, Scott M Dehm. Co-evolution of gene copy number and structural complexity in endocrine therapy resistant prostate cancer. NAR cancer. 2023, 5 (3): zcad045Cited : 5Read More
- 20)- Vasiliki Papadaki, Zoi Erpapazoglou, Maria Kokkori, Malgorzata Ewa Rogalska, Myrto Potiri, Andrada Birladeanu, Eleni N Tsakiri, Hassan Ashktorab, Duane T Smoot, Katerina Papanikolopoulou, Martina Samiotaki, Panagiota Kafasla. IQGAP1 mediates the communication between the nucleus and the mitochondria via NDUFS4 alternative splicing. NAR cancer. 2023, 5 (3): zcad046Cited : 1Read More
- 21)- Shamayita Roy, Arvin Zaker, Arvind Mer, Damien D'Amours. Large-scale phenogenomic analysis of human cancers uncovers frequent alterations affecting SMC5/6 complex components in breast cancer. NAR cancer. 2023, 5 (3): zcad047Cited : 3Read More
- 22)- Sofia Nasif, Martino Colombo, Anne-Christine Uldry, Markus S Schröder, Simone de Brot, Oliver Mühlemann. Inhibition of nonsense-mediated mRNA decay reduces the tumorigenicity of human fibrosarcoma cells. NAR cancer. 2023, 5 (3): zcad048Cited : 4Read More
- 23)- Reynand Jay Canoy, Anna Shmakova, Anna Karpukhina, Nikolai Lomov, Eugenia Tiukacheva, Yana Kozhevnikova, Franck André, Diego Germini, Yegor Vassetzky. Specificity of cancer-related chromosomal translocations is linked to proximity after the DNA double-strand break and subsequent selection. NAR cancer. 2023, 5 (3): zcad049Cited : 0Read More
- 24)- Junyoung Park, Ji-Young Kim, Jin Woo Park, Joo Young Kang, Hyein Oh, Ja Young Hahm, Yun-Cheol Chae, Debabrata Chakravarti, Sang Beom Seo. INHAT subunit SET/TAF-Iβ regulates PRC1-independent H2AK119 mono-ubiquitination via E3 ligase MIB1 in colon cancer. NAR cancer. 2023, 5 (3): zcad050Cited : 1Read More
- 25)- Brian O'Sullivan, Cathal Seoighe. Comprehensive and realistic simulation of tumour genomic sequencing data. NAR cancer. 2023, 5 (3): zcad051Cited : 0Read More
